Company: CHNR
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001079973-25-000143
Chunk: 165

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-01-27
Form: POS AM
Chunk 165
---
 in the table below (as such table may be amended from time
to time by means of an amendment to the registration statement of which this prospectus forms a part or by a supplement to this prospectus)
and (ii) any donees, pledgees, transferees or other successors-in-interest that acquire any of the Resale Securities covered by this prospectus
after the date of this prospectus from the named Selling Shareholders as a gift, pledge, partnership distribution or other non-sale related
transfer.

Certain of the Selling
Shareholders have purchased their respective Common Shares at prices lower than current market prices and may therefore experience a positive
rate of return on their investment, even if our public shareholders experience a negative rate of return on their investment. As a result,
the Selling Shareholders are able to recognize a greater return on their investment than shareholder or holders of Warrants acquired in
the public market. Furthermore, the Selling Shareholders may earn a positive rate of return even if the price of the Ordinary Shares declines
significantly. As a result, the Selling Shareholders may be willing to sell their shares at a price less than shareholders that acquired
their Common Shares in the public market or at higher prices than the price paid by such Selling Shareholders, the sale of which would
result in the Selling Shareholder realizing a significant gain even if other CHNR shareholders experience a negative rate of return.

The sale or possibility
of sale of the Common Shares, including those pursuant to this prospectus, could have the effect of increasing the volatility in Common
Share price or putting significant downward pressure on the price of Common Shares. The Common Shares being offered for resale by the
Selling Shareholders pursuant to this prospectus represent approximately 10.77% of our total issued and outstanding Common Shares on a
fully diluted basis (assuming and after giving effect to the issuance of 1,190,297 Common Shares upon exercise of all outstanding warrants).

The table below sets
forth, as of the date of this prospectus, the name of the Selling Shareholders for which we are registering Resale Securities for resale
to the public, and the aggregate principal amount that the Selling Shareholders may offer pursuant to this prospectus. In accordance
with SEC rules, individuals and entities below are shown as having beneficial ownership over securities they own or have the right to
acquire within 60 days, as well as securities for which they have the right to vote or dispose of such securities. Also, in accordance
with SEC rules,